Therapeutic approaches in young women with advanced or metastatic breast cancer

被引：3

作者：

Garcia Palomo, Andres ^{[1
]}

机构：

[1] Hosp Leon, Dept Med Oncol, Leon 24701, Spain

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2010年 / 123卷

关键词：

2 MULTICENTER TRIALS; POSTMENOPAUSAL WOMEN; AROMATASE INHIBITORS; RANDOMIZED-TRIAL; PLUS; SURVIVAL; ANASTROZOLE; FULVESTRANT; CAPECITABINE; CHEMOTHERAPY;

D O I：

10.1007/s10549-010-1071-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：49 / 52

页数：4

共 27 条

[1]

AGRAWAL A, 2008, ASCO M S, V26, P1091

[2] Gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment [J].

Albain, Kathy S. ;

Nag, Shona M. ;

Calderillo-Ruiz, German ;

Jordaan, Johann P. ;

Llombart, Antonio C. ;

Pluzanska, Anna ;

Rolski, Janusz ;

Melemed, Allen S. ;

Reyes-Vidal, Jose M. ;

Sekhon, Jagdev S. ;

Simms, Lorinda ;

O'Shaughnessy, Joyce .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) :3950-3957

[3] Third consensus on medical treatment of metastatic breast cancer [J].

Beslija, S. ;

Bonneterre, J. ;

Burstein, H. J. ;

Cocquyt, V. ;

Gnant, M. ;

Heinemann, V. ;

Jassem, J. ;

Koestler, W. J. ;

Krainer, M. ;

Menard, S. ;

Petit, T. ;

Petruzelka, L. ;

Possinger, K. ;

Schmid, P. ;

Stadtmauer, E. ;

Stockler, M. ;

Van Belle, S. ;

Vogel, C. ;

Wilcken, N. ;

Wiltschke, C. ;

Zielinski, C. C. ;

Zwierzina, H. .

ANNALS OF ONCOLOGY, 2009, 20 (11) :1771-1785

[4] Ovarian ablation or suppression in premenopausal early breast cancer: Results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial [J].

Bliss, J. M. ;

Johnson, L. ;

Lawrence, D. ;

Peto, J. ;

Price, D. ;

Yarnold, J. ;

Barrett-Lee, P. ;

Brunt, A. M. ;

Dodwell, D. ;

Earl, H. ;

Fernando, I. ;

Foster, L. ;

George, W. D. ;

Harnett, A. M. ;

Perren, T. ;

Poole, C. ;

Raina, V. ;

Robinson, A. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07) :516-525

[5] Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? [J].

Cardoso, F ;

Di Leo, A ;

Lohrisch, C ;

Bernard, C ;

Ferreira, F ;

Piccart, MJ .

ANNALS OF ONCOLOGY, 2002, 13 (02) :197-207

[6] Double-blind, Randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: Results from EFECT [J].

Chia, Stephen ;

Gradishar, William ;

Mauriac, Louis ;

Bines, Jose ;

Amant, Frederic ;

Federico, Miriam ;

Fein, Luis ;

Romieu, Gilles ;

Buzdar, Aman ;

Robertson, John F. R. ;

Brufsky, Adam ;

Possinger, Kurt ;

Rennie, Pamela ;

Sapunar, Francisco ;

Lowe, Elizabeth ;

Piccart, Martine .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1664-1670

[7] Novel therapeutic approaches to the treatment of metastatic breast cancer [J].

Fernandez, Yolanda ;

Cueva, Juan ;

Palomo, Andres G. ;

Ramos, Manuel ;

de Juan, Ana ;

Calvo, Lourdes ;

Garcia-Mata, Jesus ;

Garcia-Teijido, Paula ;

Pelaez, Ignacio ;

Garcia-Estevez, Laura .

CANCER TREATMENT REVIEWS, 2010, 36 (01) :33-42

[8] Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer [J].

Ferrara, N ;

Hillan, KJ ;

Gerber, HP ;

Novotny, W .

NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) :391-400

[9] Lapatinib plus capecitabine for HER2-positive advanced breast cancer [J].

Geyer, Charles E. ;

Forster, John ;

Lindquist, Deborah ;

Chan, Stephen ;

Romieu, C. Gilles ;

Pienkowski, Tadeusz ;

Jagiello-Gruszfeld, Agnieszka ;

Crown, John ;

Chan, Arlene ;

Kaufman, Bella ;

Skarlos, Dimosthenis ;

Campone, Mario ;

Davidson, Neville ;

Berger, Mark ;

Oliva, Cristina ;

Rubin, Stephen D. ;

Stein, Steven ;

Cameron, David .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26) :2733-2743

[10] Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma - A prospectively planned combined survival analysis of two multicenter trials [J].

Howell, A ;

Pippen, J ;

Elledge, RM ;

Mauriac, L ;

Vergote, I ;

Jones, SE ;

Come, SE ;

Osborne, CK ;

Robertson, JFR .

CANCER, 2005, 104 (02) :236-239

← 1 2 3 →